AEGiS-Reuters: Tea May Offer Treatment to Fight HIV - Japan Study

Reuters, Ltd.Important note: Information in this article was accurate in 2003. The state of the art may have changed since the publication date.
Click here to return to Reuters main menu






DonateNow


Tea May Offer Treatment to Fight HIV - Japan Study

Reuters NewMedia - Monday November 10, 2003
Christopher Doering


WASHINGTON (Reuters) - Japanese researchers said on Monday they had discovered a molecule in tea that could block the spread of the AIDS virus.

The lab findings could offer a novel way to combat the HIV infection by preventing the virus from spreading throughout the body, scientists said. Current treatments that target HIV fight the infection after it has spread.

Scientists at the University of Tokyo, led by Kuzushige Kawai, found a compound called epigallocatechin gallate or EGCG, the element believed to contain most of the health benefits found in green tea, rapidly attaches to the doorways that the AIDS virus uses to invade cells.

HIV prefers to infect cells called CD4 T-cells, and uses a molecular doorway called the CD4 receptor to do so.

By bonding with the CD4 molecule first, EGCG effectively prevents the HIV virus from attaching -- at least in lab dishes.

"This potentially opens up an avenue for preventing HIV infections," said Dr. William Shearer, a professor at Baylor College of Medicine in Houston, who wrote an editorial that accompanied the study. "Is there something here that mother nature is trying to tell us?"

Writing in the Journal of Allergy and Clinical Immunology, the researchers said they are still looking to explain why EGCG is attracted to CD4 molecule, in the hope of making it work even better.

Earlier studies have showed that people who drink a lot of tea have lower rates of cancer, heart disease and rheumatoid arthritis. In September, the U.S. Department of Agriculture found people who drank black tea saw their cholesterol drop between 7 and 11 percent.

Simply drinking tea would probably not be enough to prevent HIV infection, Shearer said. If EGCG is shown to work in a living animal, it would have to be concentrated, perhaps in a pill.

The lab study found that EGCG attached to 80 percent of CD4 receptors after five minutes and to virtually all of them after 30 minutes.

The popularity of tea has soared during the last decade.

According to the Tea Association of the United States, total sales of tea in 2002 were $5.03 billion, up from $1.84 billion in 1990.


031110
RE031109


Copyright © 2003 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.   Contact Reuters.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .